Latest News About Charm

Here are the latest publicly available updates about Charm Therapeutics and CHARM Security, based on recent press releases and company pages.

Charm Therapeutics (drug discovery company)

• September 2, 2025: CHARM Therapeutics announced an $80 million Series B financing to advance development of its AI-designed menin inhibitor for AML, with NEA and SR One leading the round. This funding supports advancing its lead candidate and broader pipeline.[3]
• September 8–9, 2025: Announcement of Dr. Erkut Bahceci as Chief Medical Officer, alongside ongoing Series B activity and strategic hires to accelerate clinical programs.[3]
• November 2025: CHARM Therapeutics continued press activity highlighting progression of CHM-029, their next-generation menin inhibitor, toward clinical development, including preclinical dose-dependent tumor data and plans for first-in-human studies.[4][3]
• Earlier history: The company launched in 2022 with a Series A to transform structure-based drug discovery using DragonFold AI technology, and has since expanded its leadership and pipeline.[6][3]

CHARM Security (AI-powered customer security platform)

• March 25, 2025: Charm Security emerged from stealth with $8 million in seed funding to combat scams and social engineering by leveraging AI to secure customer interactions and reduce human-vulnerability risks.[1]
• Ongoing 2024–2025: The company positioned itself as a security platform focused on protecting customers from social engineering, with activity and coverage in press releases and industry channels (seed funding round cited above).[1]

Notes and how this might affect you

• If you’re tracking biotech investment activity, Charm Therapeutics’ Series B and leadership appointments signal strong momentum and potential for notable updates in 2026, including clinical milestones for CHM-029.[4][3]
• If you’re evaluating cybersecurity startups or vendor options for customer security, Charm Security’s seed-backed launch indicates a growing focus on AI-assisted defense against social engineering and scams, with potential product and deployment updates in 2025–2026.[1]

Would you like a compact timeline of Charm Therapeutics’ key milestones or a quick comparison table between Charm Therapeutics and Charm Security? I can also pull the most recent press releases or investor updates if you specify which area you’re most interested in.

Citations:

• Charm Therapeutics funding and leadership updates[3][4]
• Charm Therapeutics early launch and DragonFold AI context[6]
• Charm Security seed funding and focus on scams and social engineering[1]